FineMark National Bank & Trust’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-114
| Closed | -$14K | – | 1099 |
|
|
2016
Q4 | $14K | Hold |
114
| – | – | ﹤0.01% | 895 |
|
|
2016
Q3 | $14K | Sell |
114
-169
| -60% | -$20.8K | ﹤0.01% | 880 |
|
|
2016
Q2 | $33K | Hold |
283
| – | – | ﹤0.01% | 718 |
|
|
2016
Q1 | $39K | Hold |
283
| – | – | ﹤0.01% | 643 |
|
|
2015
Q4 | $54K | Buy |
283
+1
| +0.4% | +$191 | 0.01% | 580 |
|
|
2015
Q3 | $44K | Buy |
282
+74
| +36% | +$11.5K | 0.01% | 656 |
|
|
2015
Q2 | $37K | Buy |
208
+140
| +206% | +$24.9K | ﹤0.01% | 739 |
|
|
2015
Q1 | $12K | Buy |
68
+10
| +17% | +$1.77K | ﹤0.01% | 973 |
|
|
2014
Q4 | $11K | Hold |
58
| – | – | ﹤0.01% | 1017 |
|
|
2014
Q3 | $10K | Hold |
58
| – | – | ﹤0.01% | 1027 |
|
|
2014
Q2 | $9K | Hold |
58
| – | – | ﹤0.01% | 1062 |
|
|
2014
Q1 | $9K | Sell |
58
-106
| -65% | -$16.4K | ﹤0.01% | 1075 |
|
|
2013
Q4 | $22K | Hold |
164
| – | – | ﹤0.01% | 813 |
|
|
2013
Q3 | $20K | Buy |
164
+82
| +100% | +$10K | 0.01% | 811 |
|
|
2013
Q2 | $8K | Buy |
+82
| New | +$8K | ﹤0.01% | 1015 |
|